Mani Mohindru
CIK 1664708 · Chief Executive Officer · last filed 2026-07-16
Mani Mohindru is a Chief Executive Officer who has filed 29 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing shows the insider bought $50.0K of CRDF on Jul 16, 2026. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $48.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$48.3K
4
29
-$1.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Chief Executive Officer | 59,067 | $0.82 | $48.3K | $79.9K | 9 | 2026-07-16 |
| CTMX | Director | — | $3.22 | — | $0 | 7 | 2026-06-22 |
| Tvardi Therapeutics, Inc. (CARA) Delisted | CFO & Chief Strategy Officer | 484 | $15.96 | $7.7K | -$2.05M | 10 | 2019-12-04 |
| CRIS | Chief Strategy Officer | — | $4.83 | — | $0 | 3 | 2017-02-16 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-16 | CRDF | Buy (P) | +34,364 | $50.0K | EDGAR |
| 2026-06-22 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2026-06-22 | CRDF | Buy (P) | +24,703 | $29.9K | EDGAR |
| 2026-04-02 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2026-02-18 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2025-06-30 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | CTMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CRDF | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.